Development of an in vitro model for study of the efficacy of ischemic preconditioning in human skeletal muscle against ischemia-reperfusion injury

Journal of Applied Physiology

Volumn 101, Issue 5, 2006, Pages 1335-1342

  Martou, Glyka ^a   O'Blenes, Catherine A ^a   Huang, Ning ^b   McAllister, Sandra E ^a   Neligan, Peter C ^a,b   Ashrafpour, Homa ^b   Pang, Cho Y ^a,b   Lipa, Joan E ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

ATP content; Dimethylthiazol diphenyltetrazolium bromide reduction; Hypoxia reoxygenation induced injury; Lactate dehydrogenase release

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 4 (2 HYDROXYETHYL) 1 PIPERAZINEETHANESULFONIC ACID; ADENOSINE TRIPHOSPHATE; LACTATE DEHYDROGENASE;

ARTICLE; BIOLOGICAL MODEL; CELL DAMAGE; CELL VIABILITY; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENZYME ASSAY; HUMAN; HUMAN TISSUE; HYPOXIA; IN VITRO STUDY; INFARCTION; ISCHEMIC PRECONDITIONING; MUSCLE INJURY; PRIORITY JOURNAL; REOXYGENATION; REPERFUSION INJURY; SKELETAL MUSCLE;

ADENOSINE TRIPHOSPHATE; CELL HYPOXIA; CELL SURVIVAL; FORMAZANS; HUMANS; ISCHEMIC PRECONDITIONING; MUSCLE CELLS; MUSCLE, SKELETAL; ORGAN CULTURE TECHNIQUES; OXYGEN; REPERFUSION INJURY; TETRAZOLIUM SALTS;

EID: 33751160598     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00278.2006     Document Type: Article

References (41)

1. Addison PD, Neligan PC, Ashrafpour H, Khan A, Zhong A, Moses M, Forrest CR, and Pang CY. Noninvasive remote ischemic preconditioning for global protection of skeletal muscle against infarction. Am J Physiol Heart Circ Physiol 285: H1435-H1443, 2003.
2. Blaisdell FW. The pathophysiology of skeletal muscle ischemia and the perfusion syndrome: a review. Cardiovasc Surg 10: 620-630, 2002.
3. Caroll CMA, Caroll SM, Overgor ME, Tobin G, and Barker J. Acute ischemic preconditioning of skeletal muscle prior to flap elevation augments muscle flap survival. Plastic Reconstr Surg 100: 58-65, 1997.
4. Ecker P and Schnackerz K. Ischemic tolerance of human skeletal muscle. Ann Plast Surg 26: 77-84, 1991.
5. Ghosh S, Standen NB, and Galinanes M. Preconditioning the human myocardium by simulated ischemia: studies on the early and delayed protection. Cardiovasc Res 45: 339-350, 2000.
6. Haimovia H. Vascular sutures and anastomosis. In: Vascular Surgery, edited by Ascher E. Boston, MA: Blackwell, 2004.
7. Ikonomidis JS, Tumiate LC, Weisel RD, Mickle DG, and Li RK. Preconditioning human ventricular cardiomyocytes with brief periods of stimulated ischemia. Cardiovasc Res 28: 1285-1291, 1994.
8. Jenkins DP, Pugsley WB, Alkhuleifi AM, Kemp M, Hooper J, and Yellon DM. Ischemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery. Heart 77: 314-318, 1997.
9. Jerome SN, Akimitsu J, Gute DC, and Korthius RJ. Ischemic preconditioning attenuated capillary no reflow by prolonged ischemia and reperfusion. Am J Physiol Heart Circ Physiol 268: H2063-H2067, 1995.
10. Lake KE and Woodman OL. Effect of ischemic preconditioning on vascular dysfunction induced by ischemia and reperfusion in rat hindquarters. Cardiovasc Res 32: 1081-1087, 1996.
11. Larsson J and Hultman E. The effect of long-term arterial occlusion on energy metabolism of the human quadriceps muscle. Scand J Clin Lab Invest 39: 257-264, 1979.
12. Lee HT, Schroeder CH, Shah PM, Bau SC, Thompson CI, and Belloni FL. Preconditioning with ischemia or adenosine protects skeletal muscle from ischemic tissue reperfusion injury. J Surg Res 63: 29-34, 1996.
13. Li GC, Vasquez JA, Gallagher KP, and Lucchesi BR. Myocardial protection with preconditioning. Circulation 82: 609-619, 1990.
14. Loubani M, Hassouna A, and Galinanes M. Delayed preconditioning of the human myocardium: signal transduction and clinical implications. Cardiovasc Res 61: 600-609, 2004.
15. Manktelow RT. Microvascular Reconstruction: Anatomy, Applications and Surgical Technique. New York: Springer-Verlag, 1987.
16. Mattei A, Sutter PM, Marx A, Stierli P, Hebener M, and Hurke L. Preconditioning with short cycles improves ischemic tolerance in rat fast and slow twitch skeletal muscle. Eur Surg Res 32: 297-304, 2000.
17. ATP channels in hindlimb remote ischemic preconditioning of skeletal muscle against infarction. Am J Physiol Heart Circ Physiol 288: H559-H567, 2005.
18. Moses MA, Addison PD, Neligan P, Ashrafpour H, Huang N, McAllister S, Lipa JE, Forrest CR, and Pang CY. Inducing late phase of infarct protection in skeletal muscle by remote preconditioning: efficacy and mechanism. Am J Physiol Regul Integr Comp Physiol 289: R1609-R1617, 2005.
19. Murry CE, Heannings RB, and Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemia myocardium. Circulation 74: 1124-1136, 1986.
20. Pang CY, Addison PD, Ashrafpour H, Forrest CR, Zhong A, and Neligan PC. Global protection against skeletal muscle infarction by non-invasive remote preconditioning (PC). Circulation 106: II-133, 2002.
21. Pang CY, Neligan P, Zhong A, and Forrest CR. In vivo infarct protective effect of diazoxide. Circulation 98: I-343, 1998.
22. Pang CY, Neligan P, Zhong A, He W, Xu H, and Forrest CR. Effector mechanism of adenosine in acute ischemic preconditioning of skeletal muscle against infarction. Am J Physiol Regul Integr Comp Physiol 273: R887-R895, 1997.
23. + channels in ischemic preconditioning of skeletal muscle against infarction. Am J Physiol Heart Circ Physiol 273: H44-H51, 1997.
24. Pang CY, Yang RZ, Zhong A, Xu N, Boyd B, and Forrest CR. Acute ischemic preconditioning protects against skeletal muscle infarction in the pig. Cardiovasc Res 29: 782-788, 1995.
25. Paradise NF, Schmitter JL, and Surmitis JM. Criteria for adequate oxygenation of isometric kitten papillary muscle. Am J Physiol Heart Circ Physiol 241: H348-H353, 1981.
26. ATP channel triggers delayed ischemic preconditioning in rats. Am J Physiol Heart Circ Physiol 288: H445-H447, 2005.
27. Prasad K and Callaghan JC. Effect of replacement of potassium by rubidium on the transmembrane action potential and contractility of human papillary muscle. Circ Res 24: 157-166, 1969.
28. Przyklenk K, Bauer B, Ovize M, Kloner RA, and Whittaker P. Regional ischemic "preconditioning" protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 87: 893-899, 1993.
29. Rubin BB, Romaschin A, Walker PM, Gute DC, and Korthius RJ. Mechanism of postischemic injury in skeletal muscle: intervention strategies. J Appl Physiol 80: 369-387, 1996.
30. Schulz R, Rose J, and Heusch G. Involvement of activation of ATP-dependent potassium channels in ischemic preconditioning in swine. Am J Physiol Heart Circ Physiol 267: H1341-H1352, 1994.
31. Sternbergh WC and Adellman B. Skeletal muscle fiber type does not predict sensitivity to post-ischemic damage. J Surg Res 53: 535-541, 1992.
32. Takaoka A, Nakae I, Mitsunami R, Yabe T, Morikawa S, Inubuski T, and Kinoshita M. Renal ischemia/reperfusion remotely improves myocardial energy metabolism during myocardial ischemia via adenosine receptors in rabbits: effects of remote preconditioning. J Am Coll Cardiol 33: 556-564, 2000.
33. Tortora GJ and Grabowski SR. Principles of Anatomy and Physiology (10th ed.). New York: Wiley, 2003, p. 294-295.
34. Tountas CP and Bergman RA. Tourniquet ischemia: ultra-structure and histochemical observations of ischemic human muscle of monkey muscle and nerve. J Hand Surg [Am] 2: 31-37, 1977.
35. Van Winkle DM, Thornton D, Downey DM, and Downey JM. The natural history of preconditioning: cardioprotection depends on duration of transient ischemia and time to subsequent ischemia. Coronary Art Dis 2: 613-619, 1991.
36. Walker PM. Pathophysiology of acute arterial occlusion. Can J Surg 29: 340-342, 1986.
37. Wang WZ, Anderson G, Maldonado C, and Barker J. Attenuation of vasospasm and capillary no-reflow by ischemic preconditioning in skeletal muscle. Microsurgery 17: 324-329, 1996.
38. Yang XM, Baxter GF, Heads RJ, Yellon DM, Downey JM, and Cohen MV. Infarct limitation of the second window of protection in a conscious rabbit model. Cardiovasc Res 31: 777-783, 1996.
39. Yellon DM, Alkhuleifi AM, Browne EE, and Pugsley WB. Ischemic preconditioning limits infarct size in the rat heart. Cardiovasc Res 26: 983-987, 1992.
40. Zahir KS, Syed SA, Zink JR, Restifo RJ, and Thompson JG. Ischemic preconditioning improves the survival of skin and myocutaneous flaps in a rat model. Plastic Reconstr Surg 102: 140-150, 1998.
41. Zhang JG, Ghosh S, Ockleford CD, and Galinanes M. Characterization of an in vitro model for the study of the short and prolonged effects of myocardial ischemia and reperfusion in man. Clin Sci (Lond) 99: 443-453, 2000.